ライフサイエンスコーパス: primary hyperparathyroidism

1 essful treatment for patients suffering from primary hyperparathyroidism.

2 s in serum calcium and PTH concentrations in primary hyperparathyroidism.

3 oid adenomas or hyperplasia in patients with primary hyperparathyroidism.

4 rathyroidectomy is the preferred therapy for primary hyperparathyroidism.

5 ement resulted in an excellent cure rate for primary hyperparathyroidism.

6 treatment option in geriatric patients with primary hyperparathyroidism.

7 omen with asymptomatic or mildly symptomatic primary hyperparathyroidism.

8 oid hormone response, as is typical of human primary hyperparathyroidism.

9 tinues to be the only effective treatment of primary hyperparathyroidism.

10 e may significantly change the management of primary hyperparathyroidism.

11 id tumors is tantamount to the discussion of primary hyperparathyroidism.

12 bilateral neck exploration for patients with primary hyperparathyroidism.

13 All 40 patients were cured of primary hyperparathyroidism.

14 e procedure of choice for most patients with primary hyperparathyroidism.

15 vably provide a specific medical therapy for primary hyperparathyroidism.

16 rgery is the usual therapy for patients with primary hyperparathyroidism.

17 g R-568 in 20 postmenopausal women with mild primary hyperparathyroidism.

18 concentrations in postmenopausal women with primary hyperparathyroidism.

19 more than a year and had no cause other than primary hyperparathyroidism.

20 Parathyroid carcinoma is a rare cause for primary hyperparathyroidism.

21 ion of parathyroid adenomas in patients with primary hyperparathyroidism.

22 thyroid adenomas after failed procedures for primary hyperparathyroidism.

23 f repeat surgery for persistent or recurrent primary hyperparathyroidism.

24 years) referred for parathyroidectomy due to primary hyperparathyroidism.

25 calization of enlarged parathyroid glands in primary hyperparathyroidism.

26 tive or additional tool in the evaluation of primary hyperparathyroidism.

27 ated with a decreased surgical cure rate for primary hyperparathyroidism.

28 elective venous sampling (SVS) in persistent primary hyperparathyroidism.

29 ts undergoing parathyroidectomy for sporadic primary hyperparathyroidism.

30 rd approach to the majority of patients with primary hyperparathyroidism.

31 n preoperative localization in patients with primary hyperparathyroidism.

32 complications, with a particular emphasis on primary hyperparathyroidism.

33 tions, even in individuals with asymptomatic primary hyperparathyroidism.

34 parathyroidectomy in patients with sporadic primary hyperparathyroidism.

35 l surgical approaches for many patients with primary hyperparathyroidism.

36 d for the majority of patients with sporadic primary hyperparathyroidism.

37 oidism, is recommended for all children with primary hyperparathyroidism.

38 consecutive patients undergoing surgery for primary hyperparathyroidism.

39 initial localization study for patients with primary hyperparathyroidism.

40 abnormal parathyroid glands in patients with primary hyperparathyroidism.

41 tion of parathyroid lesions in patients with primary hyperparathyroidism.

42 octogenarian and nonagenarian patients with primary hyperparathyroidism.

43 e and for treatment of certain patients with primary hyperparathyroidism.

44 ognitive changes often seen in patients with primary hyperparathyroidism.

45 090 patients were evaluated and explored for primary hyperparathyroidism.

46 hed by the 2002 NIH workshop on asymptomatic primary hyperparathyroidism.

47 success of limited neck exploration (LE) for primary hyperparathyroidism (1 degrees HPT).

48 nagement regarding the care of patients with primary hyperparathyroidism (1 degrees HPTH) has evolved

49 riods of up to 10 years in 121 patients with primary hyperparathyroidism, 101 (83 percent) of whom we

50 nts undergoing initial parathyroidectomy for primary hyperparathyroidism (2002-2014).

51 cal notes were reviewed in 143 patients with primary hyperparathyroidism (35 men, 108 women; median a

52 The most common causes of hypercalcemia were primary hyperparathyroidism (56.0%) and malignancies oth

53 Primary hyperparathyroidism, a disorder in which there i

54 Elderly patients with primary hyperparathyroidism accompanied by other disease

55 roid carcinoma is an extremely rare cause of primary hyperparathyroidism, accounting for fewer than 1

56 od, 17 patients were referred for persistent primary hyperparathyroidism after undergoing at least on

57 Using biochemical profiles of patients with primary hyperparathyroidism allows surgeons to preoperat

58 The most common etiologies are primary hyperparathyroidism and cancer.

59 ly recognized to be present in patients with primary hyperparathyroidism and critical for bone recons

60 years; range, 58-82 years) with biochemical primary hyperparathyroidism and inconclusive results at

61 Forty-eight consecutive patients with primary hyperparathyroidism and indications for surgery

62 9m)Tc-sestamibi performs well in complicated primary hyperparathyroidism and is recommended as first-

63 ntigraphy was performed on 110 patients with primary hyperparathyroidism and no prior neck surgery.

64 g repeat surgery for persistent or recurrent primary hyperparathyroidism and one patient with multipl

65 Failure to diagnose primary hyperparathyroidism and refer patients to surgeo

66 currently being tested for the treatment of primary hyperparathyroidism, and CaR-based therapeutics

67 more patients now present with asymptomatic primary hyperparathyroidism, and consensus guidelines ha

68 idneys and is seen in phosphate nephropathy, primary hyperparathyroidism, and distal renal tubular ac

69 calcemia, with prevalence similar to that of primary hyperparathyroidism, and is associated with alte

70 and mortality are increased in patients with primary hyperparathyroidism, and might be predicted by p

71 on nontraditional symptoms in patients with primary hyperparathyroidism, and open the door to the co

72 easingly important role in the evaluation of primary hyperparathyroidism, and surgical referral may b

73 tive symptoms and conditions associated with primary hyperparathyroidism as well as postoperative imp

74 ve patients undergoing parathyroidectomy for primary hyperparathyroidism at a tertiary referral cente

75 e merits of medical and surgical therapy for primary hyperparathyroidism; based on measurements of qu

76 nesota, who received an initial diagnosis of primary hyperparathyroidism between 1965 and 1992 were i

77 who underwent elective parathyroidectomy for primary hyperparathyroidism between November 1, 2006, an

78 y consecutive patients underwent surgery for primary hyperparathyroidism by a single surgeon between

79 Primary hyperparathyroidism can be cured by removal of t

80 Primary hyperparathyroidism can be cured by surgical rem

81 by the intrinsic 15% rate of multiglandular primary hyperparathyroidism, combined with the imperfect

82 eased in patients undergoing reoperation for primary hyperparathyroidism compared with initial proced

83 ve patients undergoing parathyroidectomy for primary hyperparathyroidism due to parathyroid hyperplas

84 of performing imaging before any surgery for primary hyperparathyroidism, even in the case of convent

85 first-line imaging modality in patients with primary hyperparathyroidism, even without the addition o

86 dicators (CIs) were extracted from published primary hyperparathyroidism guidelines and summarized wi

87 ctioning parathyroid tissue in patients with primary hyperparathyroidism has been a longstanding diag

88 Another variant of primary hyperparathyroidism has been described in which

89 rathyroids, and intraoperative management of primary hyperparathyroidism has been observed over the p

90 Most patients with primary hyperparathyroidism have a single adenoma that w

91 Clinical guidelines for the treatment of primary hyperparathyroidism have been established by the

92 ation and intraoperative PTH assay (QPTH) in primary hyperparathyroidism have been established.

93 In the United States, most patients with primary hyperparathyroidism have few or no symptoms.

94 %-40% of patients after curative surgery for primary hyperparathyroidism (HPT) have an elevated parat

95 Primary hyperparathyroidism (HPT) in multiple endocrine

96 ing the procedure of choice in patients with primary hyperparathyroidism (HPT).

97 be a precursor of the classic hypercalcemic primary hyperparathyroidism (HPT).

98 Traditional surgery for primary hyperparathyroidism (HPTH) involves bilateral ce

99 athic hypercalciuria was diagnosed in 15.6%, primary hyperparathyroidism in 1.6%, and normocalcemic h

100 The NIH Consensus Conference on primary hyperparathyroidism in 1990 defined criteria for

101 c medical record-based tool for diagnosis of primary hyperparathyroidism in patients with chronic hyp

102 era), the age- and sex-adjusted incidence of primary hyperparathyroidism in Rochester was 15 cases pe

103 led to a sharp increase in the incidence of primary hyperparathyroidism in the early 1970s.

104 They were, however, virtually absent in primary hyperparathyroidism, in which the transition bet

105 ticle reviews the diagnosis and treatment of primary hyperparathyroidism, including recent literature

106 linical changes and presentation of sporadic primary hyperparathyroidism, including the assessment of

107 Primary hyperparathyroidism is a common and potentially

108 Primary hyperparathyroidism is a common disorder with an

109 Primary hyperparathyroidism is a common endocrine disord

110 Primary hyperparathyroidism is a common endocrine disord

111 Primary hyperparathyroidism is a frequent and potentiall

112 Primary hyperparathyroidism is an endocrine disorder cha

113 Remedial surgery for primary hyperparathyroidism is challenging and requires

114 Almost always, primary hyperparathyroidism is due to a benign overgrowt

115 Primary hyperparathyroidism is generally discovered when

116 Primary hyperparathyroidism is mainly caused by parathyr

117 Asymptomatic hypercalcemia due to primary hyperparathyroidism is managed with parathyroide

118 Primary hyperparathyroidism is rare and due to an adenom

119 Although the cause of primary hyperparathyroidism is still poorly understood,

120 Primary hyperparathyroidism is the most common cause of

121 Although primary hyperparathyroidism is the most common cause of

122 Primary hyperparathyroidism is the third most common end

123 The progressive decrease in the incidence of primary hyperparathyroidism is unexpected and suggests a

124 cular outcomes in patients with asymptomatic primary hyperparathyroidism is unproven, but data sugges

125 tional treatment for adults with symptomatic primary hyperparathyroidism, is recommended for all chil

126 ciuric hypercalcaemia (FHH), neonatal severe primary hyperparathyroidism (NSHPT) or autosomal dominan

127 continued study of the endocrine effects of primary hyperparathyroidism on brain function.

128 One hundred seventy-three patients with primary hyperparathyroidism operated on by a single surg

129 patients who had no known family history of primary hyperparathyroidism or the HPT-JT syndrome at pr

130 In patients with primary hyperparathyroidism, parathyroidectomy results i

131 ite access to routine laboratory evaluation, primary hyperparathyroidism (PHP) remains underdiagnosed

132 r each patient for an adequate management of primary hyperparathyroidism (PHP) with surgical criteria

133 Primary hyperparathyroidism (pHPT) afflicts our aging po

134 bone mineral density (BMD) in patients with primary hyperparathyroidism (pHPT) and compare those res

135 Patients with primary hyperparathyroidism (pHPT) appear to have an inc

136 Parathyroid adenomas (PAs) causing primary hyperparathyroidism (PHPT) are histologically he

137 Primary hyperparathyroidism (PHPT) contributes to the de

138 or minimally invasive parathyroidectomy for primary hyperparathyroidism (pHPT) depends on the succes

139 Importance: Primary hyperparathyroidism (pHPT) is a common clinical

140 Primary hyperparathyroidism (pHPT) is a common clinical

141 Primary hyperparathyroidism (pHPT) is a common endocrine

142 Primary hyperparathyroidism (pHPT) is a common endocrine

143 Primary hyperparathyroidism (PHPT) is a common endocrine

144 Primary hyperparathyroidism (PHPT) is a common endocrine

145 Primary hyperparathyroidism (PHPT) is a common endocrino

146 Symptomatic primary hyperparathyroidism (PHPT) is associated with in

147 parathyroid adenomas (PTA) in patients with primary hyperparathyroidism (PHPT) is unclear.

148 l and medical treatments on fracture risk in primary hyperparathyroidism (PHPT) is unknown.

149 ) imaging techniques for the localization of primary hyperparathyroidism (PHPT) may be superior to th

150 mately 90% of people with hypercalcemia have primary hyperparathyroidism (PHPT) or malignancy.

151 Definitive treatment of primary hyperparathyroidism (pHPT) with curative parathy

152 ognitive changes are common in patients with primary hyperparathyroidism (pHPT), but the associations

153 During parathyroidectomy for primary hyperparathyroidism (PHPT), discovering a minima

154 oidectomy provides definitive management for primary hyperparathyroidism (PHPT), reducing the risk of

155 crucial for minimally invasive treatment of primary hyperparathyroidism (PHPT).

156 ar imaging is paramount to direct surgery in primary hyperparathyroidism (pHPT).

157 ion of parathyroid adenomas in patients with primary hyperparathyroidism (pHPT).

158 n 4-gland parathyroid exploration (OPTX) for primary hyperparathyroidism (pHPT).

159 hyroid gland is the definitive treatment for primary hyperparathyroidism (pHPT).

160 g (ADL), in older patients with asymptomatic primary hyperparathyroidism (PHPT).

161 ally invasive parathyroidectomy (MIP) due to primary hyperparathyroidism (primary HPTH).

162 Thus, this animal model of human primary hyperparathyroidism provides direct experimental

163 Primary hyperparathyroidism requires accurate imaging to

164 s of 130 consecutive remedial operations for primary hyperparathyroidism selectively used minimally i

165 All patients with primary hyperparathyroidism should undergo localization

166 evolution of surgical management of sporadic primary hyperparathyroidism (SPHPT).

167 glands during parathyroidectomy for sporadic primary hyperparathyroidism (SPHPT).

168 screening tests are not common, symptomatic primary hyperparathyroidism tends to predominate.

169 ted with higher cure rates for patients with primary hyperparathyroidism undergoing MIP.

170 as neurophysiologic imaging in patients with primary hyperparathyroidism undergoing parathyroidectomy

171 Consecutive patients with primary hyperparathyroidism undergoing preoperative 4D-C

172 tal of 61 consecutive surgical patients with primary hyperparathyroidism underwent both (123)I/(99m)T

173 Symptoms were more common in patients with primary hyperparathyroidism versus thyroid controls, but

174 and positive predictive value of BIJ PTH for primary hyperparathyroidism were 80% and 71%, respective

175 -eight patients with biochemical evidence of primary hyperparathyroidism were imaged before parathyro

176 A total of 114 consecutive patients with primary hyperparathyroidism were included from January 8

177 cutive patients with a clinical diagnosis of primary hyperparathyroidism were included in the study.

178 year period, 1368 parathyroid operations for primary hyperparathyroidism were performed at our instit

179 ases of initial neck surgery for nonfamilial primary hyperparathyroidism were selected for analysis.

180 Twenty-one consecutive patients with primary hyperparathyroidism were studied prospectively b

181 Since 1993, 291 consecutive patients with primary hyperparathyroidism were treated with "limited"

182 of 12 studies, involving 2290 patients with primary hyperparathyroidism, were eligible for inclusion

183 chnique resulted in excellent cure rates for primary hyperparathyroidism while simultaneously decreas

184 itution retrospective study of patients with primary hyperparathyroidism who underwent a combined ima

185 Records of 462 patients with primary hyperparathyroidism who underwent preoperative i

186 Forty patients with documented primary hyperparathyroidism who underwent surgery by a s

187 liminary fashion the brains of patients with primary hyperparathyroidism with functional imaging stud

188 approach for the treatment of patients with primary hyperparathyroidism with image-localized, presum

189 ive patients underwent parathyroidectomy for primary hyperparathyroidism with ioPTH monitoring.